CME Webcast Teaches on Multimodal Analgesia: Concepts and Strategies to Reduce Opioid Use

OSUWexnerbloglogo2014 CME Webcast Teaches on Multimodal Analgesia: Concepts and Strategies to Reduce Opioid Use. With the invention of the hypodermic syringe and hollow needle in 1850, morphine began to be used for surgical procedures and post-operative pain. However, many people became addicted to morphine so chemists set out to develop safer, more effective, and less addictive opioids. Thus heroin was created by the Bayer pharmaceutical company in 1898. That was followed by the synthesis of meperidine in 1939, methadone in 1946, and fentanyl in 1960. But all of these proved to be just as addictive as morphine. And this has left physicians in general and surgeons in particular with the dilemma of how do you relieve pain and suffering without causing the harm of addiction? Fortunately, we now have some guidance. Joining the webcast to tell us about strategies to treat pain while reducing opioid doses is OSU Professor of Plastic Surgery and the Past President of the American Society of Plastic Surgeons, Dr. Jeffrey Janis.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the current epidemiology and causes of the current opioid crisis in the United States; Understand the current opioid prescribing practices for perioperative pain; and DEVELOP intra-operative and post-operative pain management strategies to reduce opioid use.

You’ll also learn about the following:

  • Whether opioids used for pain management result in opioid addiction?
  • Opioid alternatives for pain management

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Physicians About Skin Cancer

OSUWexnerbloglogo2014 CME Webcast Teaches Physicians About Skin Cancer. In the 215 years since Laennec discovered melanoma, we have learned an enormous amount about this malignancy and how to best treat it. On this CME webcast, we’re going to update you on the latest information. Joining our moderator are two skin cancer specialists from the James Cancer Hospital. Dr. Joal Beane is a surgical oncologist and Assistant Professor of Surgery at the Ohio State University. And Dr. Carlo Contreras is an Associate Professor of Surgery, also from the OSU Division of Surgical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Describe at least two advantages of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; List the 2 main classes of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; and UNDERSTAND the diagnosis and management of cutaneous melanoma.

You’ll also learn about the following:

  • Subtypes of melanoma
  • Evaluation and diagnosis
  • Indications for referral
  • Role of metastasectomy in advanced melanoma

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Interstitial Lung Disease

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Interstitial Lung Disease. Once each year, I exercise moderator’s privileges and serve as both host and presenter and so today, I’m going to be talking about a topic that is important to me, namely interstitial lung disease.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY patients with undiagnosed interstitial lung disease based on clinical, radiographic, and pulmonary function test presentations; DISTINGUISH idiopathic pulmonary fibrosis from other common interstitial diseases based on radiographic and pathologic findings; and DESCRIBE the initial management of common interstitial lung diseases including idiopathic pulmonary fibrosis, non-specific interstitial pneumonitis,
hypersensitivity pneumonitis, and sarcoidosis.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Series Teaches On Common Poisonings

OSUWexnerbloglogo2014 On-line Education Series Teaches On Common Poisonings. The American Association of Poison Control Centers manages a 24-hour hotline that is staffed by healthcare professionals with training in toxicology. Each year, U.S. poision control centers get more than 2 million calls about poison exposures, that works out to 1 poisoning every 15 seconds. Although poisonings still are most common in children between the ages of 1 and 3 years old, poisonings can and do occur in people of all ages. Therefore, it is important for all physicians who provide clinical care to patients to be familiar with the common causes of poisoning. Joining our webcast today to update you about poisoning is Assistant Professor of Emergency Medicine, Dr. Jennifer Yee.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY potential GI decontamination methods and indications; and IDENTIFY life-threatening toxicologic ingestions.

You’ll also learn about the following:

  • Common causes of poisonings
  • Use and limitations of the tox screen
  • www.webPOISONcontrol.org
  • Laundry detergent pod ingestion
  • Carbon monoxide poisoning

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Webcast Teaches Physicians About Sarcoidosis

OSUWexnerbloglogo2014 On-line Education Webcast Teaches Physicians About Sarcoidosis. On this CME webcast, we’re going to update you about the diagnosis and management of sarcoidosis.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND how to distinguish sarcoidosis from other granulomatous disorders; DESCRIBE basic concepts relating to the treatment of sarcoidosis; EXPLAIN clinical presentation, basic histology and epidemiology of sarcoidosis; and UNDERSTAND the diagnostic criteria and the differential diagnoses for sarcoidosis.

You’ll also learn about the following:

  • Organ involvement and treatment selection
  • Administration and dosing of methotrexate
  • Angiotensin Converting Enzyme levels (ACE)

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.